Salt-reducing cheese solution finalist for prestigious innovation award

Press release -

Salt-reducing cheese solution finalist for prestigious innovation award

Chr. Hansen’s newly launched SaltLite™ cheese cultures and enzymes concept, which is gaining awareness in the international cheese industry, has been selected as a finalist in the Food Ingredients Europe Excellence Awards.

SaltLite™ is a natural solution to sodium reduction in cheese. Excess salt consumption contributes to high blood pressure, a leading cause of death globally. Much of the sodium in our diets comes from the consumption of processed foods, such as cheese.

SaltLite™ consists of specifically selected bacterial cultures and enzymes to counteract the negative effects of salt reduction in cheese. In contrast to other technologies, SaltLite™ uses specially selected ingredients already used in the production of cheese.

Given demand to reduce salt levels in cheese and the innovative nature of SaltLite™, numerous international cheese producers have begun trials with the solution alone or in tandem with other salt-reduction technologies.

FIE Excellence Award finalist
Since its launch in March 2013, SaltLite™ has been selected as a finalist in the 2013 FIE Excellence Awards which will be handed out at the upcoming FI Europe trade show in Frankfurt, Germany November 19-21. SaltLite™ was also a finalist in the recent Dairy Innovation Awards.

In total, three Chr. Hansen ingredient solutions are in competition to win a 2013 FIE Award. In addition to SaltLite™, Chr. Hansen’s finalists are:

  • FreshQ®: protective cultures fighting yeast and mold in fresh dairy products in an all-natural way
  • SafePro Imporous®: new meat cultures which improve quality in cooked whole muscle products





Visit our SaltLite™ website and learn more about the solution.

Topics

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark

Chr. Hansen website
Investor Relations
Read more about Chr. Hansen
Enter your email address to follow Chr. Hansen Holding A/S

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Chr. Hansen Holding A/S.

Okay